Sol-Gel Technologies (SLGL) Liabilities and Shareholders Equity (2016 - 2026)

Sol-Gel Technologies (SLGL) reported Liabilities and Shareholders Equity of $58.6 million for Q1 2026, up 116.35% year-over-year from $27.1 million in Q1 2025, and up 95.71% quarter-over-quarter from $29.9 million in Q4 2025.

Sol-Gel Technologies (SLGL) Liabilities and Shareholders Equity (2016 - 2026) Analysis & Trends

Sol-Gel Technologies (SLGL) has 11 years of Liabilities and Shareholders Equity data on file, last reported at $58.6 million in Q1 2026.

  • Liabilities and Shareholders Equity for Q1 2026 came in at $58.6 million, up 116.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $162.4 million (up 9.79% YoY), and the FY2025 annual result was $29.9 million, down 16.54% from the prior year.
  • Liabilities and Shareholders Equity advanced to $58.6 million in Q1 2026 per SLGL's latest filing, from $29.9 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $58.6 million in Q1 2026 and troughed at $27.1 million in Q1 2025.
  • A 5-year average of $44.6 million and a median of $45.3 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
  • The sharpest annual moves came in 2022 and 2026: Liabilities and Shareholders Equity slumped 32.61% in 2022, then jumped 116.35% in 2026.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $46.6 million in 2022, then retreated by 2.88% to $45.3 million in 2023, then dropped by 20.85% to $35.8 million in 2024, then fell by 16.54% to $29.9 million in 2025, then soared by 95.71% to $58.6 million in 2026.
  • Business Quant data shows SLGL's Liabilities and Shareholders Equity at $58.6 million in Q1 2026, $29.9 million in Q4 2025, and $34.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 37.37 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 811.27 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 14.93 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.73 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 23.64 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 33.89 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 12.81 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 26.48 Bn
9 Abivax 91.96 Bn 91.96 Bn - 640.56 Mn
10 Sol-Gel Technologies 207.80 Mn 197.67 Mn - 58.55 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 58.55 Mn
Dec 31, 2025 29.92 Mn
Sep 30, 2025 34.59 Mn
Jun 30, 2025 39.31 Mn
Mar 31, 2025 27.06 Mn
Dec 31, 2024 35.85 Mn
Sep 30, 2024 42.98 Mn
Jun 30, 2024 42.01 Mn
Mar 31, 2024 39.91 Mn
Dec 31, 2023 45.29 Mn
Sep 30, 2023 49.86 Mn
Jun 30, 2023 55.10 Mn
Mar 31, 2023 49.04 Mn
Dec 31, 2022 46.63 Mn
Sep 30, 2022 51.29 Mn
Jun 30, 2022 54.98 Mn
Mar 31, 2022 56.06 Mn
Dec 31, 2021 69.19 Mn
Sep 30, 2021 52.83 Mn
Jun 30, 2021 46.41 Mn